ArticleOpen life sciences2022

Endostar plus pembrolizumab combined with a platinum-based dual chemotherapy regime for advanced pulmonary large-cell neuroendocrine carcinoma as a first-line treatment: A case report.

Sijia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.